# Cognitive outcomes of antidepressant use in patients with cancer: a systematic review

- URL: https://alisanburak.com/en/wcp-2026-posterler/so393
- Language: en
- Last updated: not specified
- Page title: Cognitive outcomes of antidepressant use in patients with cancer: a systematic review | WCP 2026 Summary

> In this review of seven studies, evidence for the short-term beneficial effects of antidepressants on cognitive function was more consistent than evidence for…

This page was translated automatically from Turkish. [Read the original](https://alisanburak.com/wcp-2026-posterler/so393)

Bu sayfa, 26. Dünya Psikiyatri Kongresi'nde sunulan çalışmanın yapay zekâ desteğiyle hazırlanmış Türkçe özetidir. Çalışmanın sahibi sunan yazarlardır; atıf için orijinal kaynağa başvurun.

SO393

Kısa Sözlü Poster SunumuPsikofarmakolojiSistematik derleme

# Cognitive outcomes of antidepressant use in patients with cancer: a systematic review

COGNITIVE OUTCOMES OF ANTIDEPRESSANT USE IN PATIENTS WITH CANCER: A SYSTEMATIC REVIEW

Sunan: Michela Bellezza

Ülke: Italy

Kurum: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Oturum: 4400 - PARALLEL SHORT ORAL POSTER SESSIONS: CONSULTATION LIAISON - Part IV

Tarih: Sat, 26.09.2026

In this review of seven studies, evidence for the short-term beneficial effects of antidepressants on cognitive function was more consistent than evidence for their long-term effects.

The aim of the study was to evaluate the effects of antidepressant medications on cognitive function in patients with cancer. This systematic review, conducted using PubMed in accordance with PRISMA guidelines, included studies reporting cognitive outcomes in domains such as attention, memory, executive function, processing speed, working memory, semantic fluency, and visuospatial skills in oncology populations receiving antidepressant treatment. Risk of bias was assessed using standardized tools. According to the flow diagram, 476 records were screened and 469 reports were assessed for eligibility; the reasons for exclusion were reported as review (n = 174), irrelevant (n = 158), in vivo (n = 59), outside the scope (n = 48), case report (n = 21), in vitro (n = 6), and opinion piece (n = 3), with seven studies meeting the inclusion criteria (n = 7). Studies examining short-term antidepressant use reported potential cognitive benefits associated with sertraline, vortioxetine, and low-dose esketamine, particularly with respect to executive function and perioperative neurocognitive disorders; these findings were accompanied by improvements in depressive symptoms. Findings from studies focusing on long-term outcomes were heterogeneous. Overall, the available evidence is more consistent in supporting the short-term benefits of antidepressants on cognitive function than their long-term effects; however, the evidence base is limited by the small number of studies in this field. Clinically, this suggests that cognitive outcomes may be considered when selecting antidepressants for patients with cancer, but that no strong recommendation can be made regarding long-term cognitive effects.

[Orijinal postere git](https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/319)

Bu çalışmaya nasıl atıf yapılır?

APA 7: Bellezza, M., et al. (2026, September 26). Cognitive outcomes of antidepressant use in patients with cancer: a systematic review [Poster presentation]. 26th WPA World Congress of Psychiatry (WCP 2026), Stockholm, Sweden. https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/319

Vancouver: Bellezza M, et al. Cognitive outcomes of antidepressant use in patients with cancer: a systematic review [poster]. 26th WPA World Congress of Psychiatry (WCP 2026); 2026 Sep 23-26; Stockholm, Sweden. Available from: https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/319

Yazar adları ve başlık biçimi kongre sisteminden otomatik oluşturulmuştur; kullanmadan önce orijinal posterle karşılaştırın.

## Aynı konudan

- [Açığı kapatmak: erişkin DEHB ilacı başlanmadan önce EKG sevk uyumunun iyileştirilmesi, kapalı döngü klinik denetim](https://alisanburak.com/en/wcp-2026-posterler/ev0088)
- [Anksiyete bozukluğu olan hastalarda psikobiyotik müdahalesi: ısıl işlem görmüş Lactobacillus paracasei PS23'ün etkilerini inceleyen çift kör randomize kontrollü çalışma](https://alisanburak.com/en/wcp-2026-posterler/ev0126)
- [Otizm spektrum bozukluğunda bumetanidin tedavi edici potansiyeli: güncel kanıtlar ve gelecek yönelimleri](https://alisanburak.com/en/wcp-2026-posterler/ev0157)
- [Verbaskozid ile otizm spektrum bozukluğu tedavisinin mekanizmaları: ağ farmakolojisi, moleküler yerleştirme ve moleküler dinamik temelli inceleme](https://alisanburak.com/en/wcp-2026-posterler/ev0172)
- [Otizm spektrum bozukluğunun çekirdek belirtilerinin tedavisinde kannabidiol: sistematik derleme](https://alisanburak.com/en/wcp-2026-posterler/ev0186)

[Tüm WCP 2026 özetleri](https://alisanburak.com/en/wcp-2026-posterler)

---

Kaynak / Source: https://alisanburak.com/en/wcp-2026-posterler/so393

İletişim / Contact: Bağdat Caddesi, Veli Güneysu Apt. No:453 K:4 D:9, Suadiye / Kadıköy, İstanbul · +90 532 642 95 25 · info@alisanburak.com · https://alisanburak.com/bagdat-caddesi-psikoterapi-iletisim